Early screening method and kit for Graves' disease (GD) susceptibility genes
A technology for goiter and susceptibility genes, which is applied in the directions of biochemical equipment and methods, determination/examination of microorganisms, DNA/RNA fragments, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0108] Feasibility Analysis of SNP Site Screening of Human Diffuse Toxic Goiter Susceptibility Genes
[0109] The inventors screened and evaluated the loci related to the occurrence of diffuse toxic goiter, which were verified by the genome-wide association study (GWAS) of NCBI at home and abroad in large-scale pathological control group clinical studies , selected 17 single nucleotide polymorphism sites that are significantly associated with the risk of diffuse toxic goiter in the Chinese population, and are independent of each other, there is no linkage disequilibrium, so the site selection of the present invention is representative and independent It can be used to assess the risk of diffuse toxic goiter in individuals.
[0110] The screened SNP sites are as follows:
[0111] rs2294025、rs7005834、rs2941522、rs907091、rs1453559、rs12150079、rs2872507、rs3087243、rs231775、rs229527、rs2284038、rs4969170、rs12101261、rs179243、rs40401、rs2069812、rs2227306。
Embodiment 2
[0112] Embodiment 2 system verification
[0113] System validation includes accuracy, specificity, sensitivity, precision, and comparison among personnel.
[0114] Accuracy verification scheme: 20 cases were detected at each site, compared with Sanger sequencing, the expected target was 95%.
[0115] Specificity Validation Protocol: Included in Accuracy, expected target 95%.
[0116] Sensitive verification scheme: using human genomic DNA positive samples as templates, the DNA contents of calibration samples were 1ng / μL, 5ng / μL, 10ng / μL, 50ng / μL, and 100ng / μL for sensitivity inspection.
[0117] The precision verification plan (including intra-batch, inter-batch, and personnel comparisons, not involving inter-instrument comparisons) has an expected target of 95%.
[0118] Intra-assay precision: The same batch of each sample was repeated 3 times to compare the intra-assay precision.
[0119] Inter-batch precision: The same operator tests the same sample in multiple batches to...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com